Press Releases
EndoGastric Solutions Announces New Sham-Controlled European Study Demonstrates Transoral Incisionless Fundoplication (TIF) Procedure as Effective Alternative for Daily PPI Treatment
Study Found 59% of Patients Undergoing TIF Procedure Had Remission of Gastroesophageal Reflux Disease Symptoms after Six Months REDMOND, Washington; October 15, 2015 – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal...
EndoGastric Solutions Announces AMA Assignment of CPT Code and Short Form Descriptor
New CPT Code for the TIF Procedure Becomes Effective January 1, 2016 REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy to treat Gastroesophageal Reflux Disease (GERD), announced today assignment of Category I Current...
Expert Presented Significant Body of Data from Randomized Controlled Trials of EndoGastric Solutions®’ Transoral Incisionless Fundoplication (TIF®) Procedure for GERD at SAGES 2015
Data shows positive results from 192 patients followed up to 12-months at multiple centers SAN MATEO, Calif. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced that Karim Trad, MD,...
EndoGastric Solutions Announces AMA’s Publication of New Category I CPT Code for Esophagogastric Fundoplasty Trans-Orifice Procedure
Publication of New Category I CPT Code is an Important Step in Establishing Access to Minimally Invasive Technology for Patients with Reflux SAN MATEO, Calif.–EndoGastric Solutions (EGS), developer of an incisionless approach to treat Gastroesophageal Reflux Disease...
EndoGastric Solutions Announces Publication of Landmark Data in Gastroenterology Demonstrating Superiority of Transoral Incisionless Fundoplication For Treatment of Troublesome Regurgitation
Significantly More TIF/Placebo Patients Experienced Elimination of Troublesome Regurgitation as Compared to Sham/PPI Patients SAN MATEO, Calif.–EndoGastric Solutions (EGS) announces that Gastroenterology, the official journal of the American Gastroenterological...
EndoGastric Solutions Advances EsophyX® Platform with the Launch of EsophyX®2 HD Device
Now physicians can utilize the latest-generation high definition (HD) endoscopes when performing Transoral Incisionless Fundoplication (TIF®) procedures to treat the underlying, anatomical causes of GERD SAN MATEO, Calif. (Dec. 10, 2014)–EndoGastric Solutions® (EGS),...
Incisionless Procedure Improves Long-Term GERD Symptoms, 70% of Patients Are Able to Stop Taking Proton Pump Inhibitor Medications for Two Years
EndoGastric Solutions Reports Two-Year Durability Data from TIF Registry for GERD Patients Choosing Transoral Incisionless Fundoplication (TIF®) SAN MATEO, Calif. (Oct. 29, 2014)–EndoGastric Solutions® (EGS) announced publication of US registry data showing that...
EndoGastric Solutions announces TIF® Procedure Significantly More Effective than PPI in Eliminating Troublesome Regurgitation in Patients with Long-Term GERD
Six-month results of the first-ever sham and placebo-controlled study of a transoral endoscopic procedure for GERD presented at American College of Gastroenterology (ACG) 2014 Annual Scientific Meeting SAN MATEO, Calif. (Oct. 20, 2014)–EndoGastric Solutions (EGS)...
EndoGastric Solutions Announces Publication of Study Demonstrating Benefits of TIF procedure in Controlling GERD Symptoms
Prospective, Randomized Study Showed Durability of Clinical Outcomes in the TIF group and Improved Control of GERD symptoms in the Crossover Group SAN MATEO, Calif. (Oct. 8, 2014)–EndoGastric Solutions® (EGS), a leader in endoluminal reconstructive treatment for...